glp-1 agonist equivalent doses Practice Nurse GLP-1 medications are marketed to

They are not intended for short-term or cosmetic weight loss

The greater interest among groups disproportionately affected by severe obesity [2, 46] and its related comorbidities may reflect a recognition of the potential health benefits of weight-loss medications for these people [27, 28]

[7] [8] GLP-1 receptor agonists (such as semaglutide, liraglutide, and dulaglutide) are now widely prescribed medications for type 2 diabetes and obesity management, approved by the MHRA and recommended in NICE guidelines (NG28 for type 2 diabetes

2021;36:ii3ii9

Yet, there are also risks worth considering

The researchers also found no significantly increased risk for suicidal ideation in the review